VIVXF News and Press, Avivagen From 01/27/22

4Q21 Results. Avivagen's management reported revenue of $368,504 (all figures in Canadian $) in the quarter, up from $287,897 last year, but down from our estimated revenue of $1.4 million. The miss is mostly due to a Philippines order that will be recognized in the first quarter of fiscal 202...

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting gener...

OTTAWA, Ontario, January 19, 2022--(BUSINESS WIRE)--Avivagen Inc. (TSXV:VIV) ("Avivagen" or the "Company") today reported its audited financial results for the year ended October 31, 2021. Unless otherwise noted, all figures are in Canadian currency. Read More >>

New Order. Avivagen signed a significant new purchase agreement to supply its largest customer in Asia with a 6.3 tonne order of OxC-beta Livestock. The shipment represents a 43% increase in size over the customer’s previous order and continues a trend of increased reorder size among th...

6.3 tonne order represents a 43% increase over most recent shipment to same customer Growth during pandemic signals strong impact on market share through use of OxC-beta™ Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences cor...

Agreement. As we had anticipated, Avivagen has entered into a distribution agreement focused on the U.S., Brazil, and Thailand markets. The 8-year agreement is with AB Vista. We expect the agreement to expand the adoption and use of OxC-beta in a number of high-value feed production markets wo...

-AB Vista becomes the exclusive distribution partner for OxC-beta™ for poultry, swine, ruminants (dairy and beef) and aquaculture uses in the United States, Brazil and Thailand -Webcast to take place Wednesday, October 6th, 2021, at 10:30 a.m. EDT Avivagen Inc...

Eight-year agreement expected to increase OxC-Beta™ access and adoption in the largest feed production markets worldwide AB Vista to become exclusive distributor for use with poultry, swine, ruminants and aquaculture in United States, Brazil and Thailand AB Vista and Av...

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), after releasing its third quarter results yesterday is pleased to provide further detail about product shipments during the third quarter in order to address questions it has received from investors following its earlier ...

3Q21 Results. Avivagen reported revenue of $505,866 in the quarter, down from $612,530 last year. We had estimated revenue of $1.0 million. The majority of the miss comes from a 3.5 million tonne order shipped in the quarter for which the revenue has yet to be recognized. We estimate the delay...